Journal article

The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine

Joseph Torresi

Frontiers in Microbiology | FRONTIERS MEDIA SA | Published : 2017

DOI: 10.3389/fmicb.2017.02163

Download PDF

University of Melbourne Researchers

Related Projects (2)

Project icon

HEPATITIS C VACCINE

Hepatitis C virus is responsible for over 300,000 deaths per year world wide and in Australia causes 10,000 new cases each year. A vaccine t..

Project icon

DEVELOPING A QUADRIVALENT HCV VACCINE

A vaccine for hepatitis C virus (HCV) is not yet available. Immune responses that are able to protect against infection are possible, making..

Grants

Awarded by National Health and Medical Research Council (NHMRC) of Australia

Awarded by NHMRC Practitioner Fellowship

Funding Acknowledgements

This work was supported by the National Health and Medical Research Council (NHMRC) of Australia, grant numbers 1060436 and 1126379. JT is supported by an NHMRC Practitioner Fellowship, grant number 106043.

Citation metrics

6Web of Science
8Scopus
9Dimensions

Keywords

Neutralizing Antibody
Human Monoclonal-Antibodies
Hepatitis C
Life Sciences & Biomedicine
Virus Like Particles
E2 Glycoprotein
Hepatitis-C-Virus
Injecting Drug-Users
T-Cell Responses
Microbiology
Sustained Virological Response
Immune-Responses
Science & Technology
B Surface-Antigen
Hepatitis C Vaccines
Envelope Glycoprotein 2
Broadly Neutralizing Antibodies